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Abstract
Background: Health intervention program (HIP) based on diet and lifestyle modifications had been shown to
improve cardiovascular risks. The effects of such program on a variety of cardiometabolic outcome measures
conducted in a strict analysis remained relatively unexplored.
Materials and methods: A total of 2,660 participants (mean age: 43.3 ± 10 years, 63.6 % male) underwent annual
health survey from our health evaluation department. We implemented health intervention program (HIP) in
which diet and lifestyle modifications including smoking cessation and advised physical activities were
introduced. We further studied the effects of HIP on several cardiometabolic outcome measures including
Framingham, metabolic scores and renal function in terms of Egfr with a mean follow-up period of 38.5 months.
Propensity score (PS) matching (HIP vs non-HIP group) was used to avoid effects of case selection bias.
Results: Totally 1,004 (502 subjects for each group) left after PS matching protocol (both HIP and non-HIP
group). The HIP group showed significant decline of waist circumference (−1.46 ± 0.61, p = 0.016), post-prandial
glucose (−6.77 ± 2.06, p = 0.001), and total cholesterol level (−4.42 ± 2.15, p = 0.04), with borderline increase in
eGFR (1.72 ± 0.94, p = 0.068) after an average of 1.91 ± 1.14 year follow up period. Exercise behavior significantly
increased for those who received HIP when compared to the non-HIP group (44.6 vs 52.4 %, p = 0.014). PS
matching and difference-in-difference (DID) analysis further confirmed the beneficial effects of ATP III reduction
by HIP (−0.36 ± 0.06, p < 0.05).
Conclusion: We demonstrated in our study that several cardiometabolic profiles can be substantially improved
after health intervention introduction at the health evaluation center, supporting the beneficial evidence of such
health intervention programs implementation based on primary prevention view points.
Keywords: Health promotion, Cardiometabolic profiles, Propensity matching, Primary prevention
Introduction
The total estimated financial burden of cardiovascular
disease (CVD) for 2009 had reached $475.3 billion in the
united states, [1] with the averaged lifetime cost of ische-
mic stroke in the US estimated to be $140,048. The un-
awareness of early stage weight control or life style and
dietary modification so far remained as the major causes
of subsequent development of CVD. Thus far, Framing-
ham risk score (FRS), a fairly robust scoring system with
well-validated longitudinal epidemiological data, and had
been used broadly as a “gold-standard” in projecting
future cardiovascular risks [1]. On the other hand, meta-
bolic syndrome, [2, 3], which takes a cluster of metabolic
derangements tightly linked to cardiovascular disorders
with central obesity as key clinical feature, had been
demonstrated to identify subject to adverse cardiovascu-
lar outcomes in the past decade [3–6]. Compared to
FRS, cardiovascular risk stratification based on the
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metabolic scoring is composed of more modifiable car-
diometabolic risk factors and prone to lifestyle modifica-
tion and health intervention.
Health intervention programs (HIP), which actually
comprised of health promotion, counseling and asso-
ciated education programs adopted by several earlier
healthcare organizations based on the modification of
health behaviors and dietary control, is of extraordin-
ary clinical value in disease prevention and therapeutic
intervention [7–10]. Therefore, hospitals should be
implemented with cost-effective primary preventive
practices both for disease prevention and health pro-
motion. The health evaluation center, an emerging
new medicare unit nearest to primary and preventive
medicine, should theoretically play an pivotal role to
develop or to screen and provide educative care deliv-
ery for selected subjects in need. However, there re-
mains a gap between the ideal implementation of
health promotion programs and the actual efficacy in
a large volume unit from real world practice.
The aim of this study was to investigate whether the
health promotion implementation may lead to effective
and significant effects on cardiometabolic risk profiles




In addition to the routine and traditional offer of
standard physical examination, clinical information or
biochemical data collection, a health intervention pro-
gram (HIP) was developed and was further funded as a
new component of our routine health evaluation pro-
cedure at the health evaluation center from a tertiary
medical center in Northern Taipei, Taiwan in 2002.
The health intervention program (HIP) from our
health examination center includes the following 3
components:
1) health education guidance preceding a health evalu-
ation; 2) establishment of health management profiles;
and 3) follow-up care and tracking. Follow-up tracking
is managed by health management specialists using the
Health Management Information System. This system
not only records all health evaluation test results, phys-
ician diagnoses, physician recommendations and dates
and times of the referral appointments, but also provides
a list of abnormal results and the annual health evalu-
ation comparison for patients who had at least two con-
secutive visits. This system can also facilitate specialists
to track and provide follow-up care. After initially run-
ning of nearly 2 years to get the system, we started to
conduct a health promotion protocol in our health
evaluation center.
Study design
In our current study cohort, we analyzed the effects of
such HIP implemented from those individuals who
underwent two consecutive health evaluations between
January 2004–2009. A physician specializing in family or
internal medicine provides patients with a systematic
explanation of their health evaluation report on the day
following examinations. The content of the report in-
cludes test results, physical examination results, special-
ist recommendations, a summary and explanation of the
results, and appropriate health education. Follow-up
visits are scheduled with prescriptions done immediately
as well as the referral and registration procedures
performed on the same day. For patients who require
follow up visits, appointment was made by health man-
agement specialists. Subjects not eligible and precluded
in our health evaluation center may include unstable
clinical conditions including acute decompensated heart
failure, acute coronary syndrome, acute cerebrovascular
event or renal replacement therapy. We intended to
invite all subjects to participate our HIP program. How-
ever, since not all subjects were willing to participate
this program, we further categorize the baseline sample
into two groups: those who received health promotion
interventions (HIP group) and those who did not (non-
HIP group). In brief, HIP programs were characterized
by both nutrition-based health education on diet habit
and lifestyle modification as the following items: 1) edu-
cation provided with the essential information on modi-
fiable, diet-related disorders including less salt intake, to
minimize food/diet exposure enriched in cholesterol and
sugars, and 2) further highlighted the concept of lifestyle
modification including increasing exercise or physical
activities, smoking cessation, optimization of alcohol
use, regular daily life schedule planning or tasks man-
agement to avoid staying up late. Education was pro-
vided by individualized instruction from special trainee/
specialist in our center. A detailed study protocol and
components were listed in Additional file 1: Table S1.
Study subjects recruitment and flowchart
From the initial 28,344 persons who underwent health
evaluation were eligible for our analysis, 19,686 persons
who either had only one health evaluation or had a very
short interval between two consecutive visits that was
shorter than 36 months, leading to a total of 8,658 indi-
viduals remained. A total of 6,745 persons completed
the questionnaires, while the remaining 1,913 persons
were excluded. After further exclusion of those due to
missing data (n = 1,876), incomplete reports (1,700),
subjects with extreme values after descriptive data ana-
lysis (n = 12), the final cohort for this retrospective study
consisted of 3,057 persons (Fig. 1). Among them, 922
subjects received HIP and 1,738 did not. The complete
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exclusion procedure of the sample is outlined in Fig. 2.
The data collected from the first health evaluations con-
stitutes the baseline, and the data collected from the
second health evaluation constitutes the follow-up.
Study procedure
The recipient of a health evaluation will track his or her
health status according to the contents of the report and
the physician’s recommendations, and will voluntarily
follow-up with the department on an outpatient basis.
Data considered includes physical examination question-
naires, satisfaction surveys, physiological and chemical
examinations, metabolic scores (ATP III), FRS, eGFR,
consultation notes from specialists, physical examination
notes from physicians, records from case managers,
follow-up care records, and the number of referrals and
their associated costs. This study was approved by the
local ethics committee of the Mackay Memorial hospital
and patient information was anonymized and de-identified
prior to analysis. This study received approval from the
institutional review board (MMH-I-S-584) to perform
retrospective research using secondary data.
Outcome measures
1. The Assessment of Metabolic Scores: ATP III risk
scores
We assessed ATP III scores at baseline and at
follow-up to quantify the change in health status
among the intervention and control groups. A
decrease in score indicates an improvement in
health status, while an increase in score or no
change in score indicates lack of improvement. Based
on National Cholesterol Education Program-Adult
Treatment Panel III (NCEP-ATP III) criteria score [11],
we measured five risk indicators using a change score
between 0 and 5, using components including: 1)
abdominal obesity (waist circumference ≥90 cm
and ≥80 cm in men and women, respectively); 2)
low high-density lipoprotein cholesterol (HDL)
(<40 mg/dl in men, <50 mg/dl in women); 3) high
triglycerides (≥150 mg/dl); 4) high blood pressure
(systolic blood pressure ≥130 mmHg or diastolic
blood pressure ≥85 mmHg); 5) and high fasting
glucose (≥100 mg/dl). According to the NCEP-ATP
III score of 0–5, individuals with a score ≥3 are
categorized as having the metabolic syndrome.
2. The Assessment of Framingham Risk Score (FRS)
The operational definition of the cardiovascular risk
assessment for Framingham Risk Score (FRS)
included indicators of cardiovascular risk established
in the National Cholesterol Education Program
(NCEP) guidelines: age, total cholesterol, HDL
cholesterol, blood pressure, and smoking status [11].
Based on the levels of risk factors, the percentage
risk of developing chronic coronary heart disease
(CHD) in the subsequent 5–10 years was quantified
according to the conversion table. Subsequently, the
Fig. 1 The age and gender distribution of original cohort from current study (n=3,057)
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cardiovascular risk can be delineated into high
(>20 %), moderate (10–20 %), or low (<10 %) [11].
This study uses the percent change in cardiovascular
risk score as the operational definition for health
status improvement.
3. Estimated Glomerular Filtration Rate (eGFR)
We relied on the Modification of Diet in Renal
Disease (MDRD) in the definition of eGFR, which
incorporated serum creatinine level into MDRD
formula [12]. The percent change of eGFR from
baseline to follow-up among the intervention and
control groups was evaluated. An increase of eGFR
score indicates health status deterioration, while a
decrease indicates health status improvement.
Statistical method
The analysis comparing the health status of the interven-
tion and control groups was completed using SPSS 17.0
statistical software. Descriptive statistical analysis includ-
ing the frequency distributions and percentages for all
study variables were assessed for the entire sample and
also according to group (intervention versus control).
Fig. 2 The flowchart of current study subjects and subjects excluded for final analysis and propensity matching
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Inferential statistical analysis of propensity score analysis
was performed by logistic regression. In order to avoid
selection bias of several key factors in the comparison of
intervention effects between HIP and non-HIP groups,
we further matched the two groups based on a propen-
sity score. The covariates included age, gender, smoking
status, drinking status, exercise status, systolic blood
pressure, diastolic blood pressure, BMI, ATP III score,
FRS score, eGFR, blood glucose level, cholesterol, HDL
cholesterol, LDL cholesterol, triglycerides, as well as
family history of hypertension, diabetes, and cardiovas-
cular diseases. We used the caliper and the radius
matching methods. In order to prove the distribution of
covariates among two groups is homogeneous, the
matching distance was set at 0.05. This matching
method reduces the effect of sampling bias and illus-
trates that the two groups consist of randomly assigned
study samples. The matching algorithm for the propen-
sity score (PS) was based on the caliper and radius
matching methods, where the caliper signifies a toler-
ance level for the maximum distance in the propensity
score. A distance of 0.05 was chosen for the current
study. The use of PS ensures homogeneity in the base-
line distributions of outcomes among the intervention
and control groups, and also avoids estimation error
caused by selection bias. Independent-samples t-test was
used to compare the differences between the means of
study continuous variables and risk indicators between
groups with Chi-squared test used to evaluate propor-
tional differences in categorical variables. Paired-t test
and McNemar test were used to examine continuous
and categorical variable changes about health improve-
ment in the intervention or control group from baseline
to follow-up.
Difference in difference (DID) analysis was intro-
duced in our study, which first calculated the difference
in a given outcome between baseline and follow-up for
each of the intervention control groups to eliminate
the potential biological changes over time. Subse-
quently, the changes in cardiovascular risk scores are
compared to estimate the differences which may reflect
the difference in the improvement of health status in




Of the initial 3,057 individuals participated the health
screen program during study period (2004–2009;
Additional file 1: Figure S1), 2,660 met eligible criteria
and were selected for final enrollment (Additional
file 1: Figure S1). Among them, 1,691 (63.6 %) were
male and 969 (36.4 %) were female, resulting in a male
to female ratio of 1.75:1. As shown in Table 1, the
mean ± standard deviation (SD) age for the entire
cohort was 43.3 ± 10.0 years, with resultant 922 and
1,738 subjects in the intervention and non-
intervention groups, respectively (Additional file 1:
Figure S2).
When comparing the HIP to the non-HIP group on
baseline demographics, lifestyle factors, medical histor-
ies, and cardiometabolic risk scoring before PS match-
ing, those who underwent intervention tended to be
older, less male gender, higher fasting glucose, HbA1c
level, total cholesterol, HDL and LDL level, higher
probability of smoking behavior, and alcohol use as well
as regular exercise life styles (all p < 0.05). When com-
pared the cardiometabolic risk scorings, the interven-
tion group tended to have worse scorings when
compared to the non-intervention group in terms of
higher ATP III (1.49 vs 1.28) and lower eGFR, though
the FRS did not show any significant differences be-
tween these two groups.
Propensity Score (PS) analysis
A total of 502 subjects from each group were identified
and following matching showed no significant differ-
ences in any of the covariates existed between the two
groups. This indicates homogeneity between the inter-
vention and control groups following PS matching. The
results of the PS are presented in Table 1 (right col-
umns), with the association between various baseline
variables and propensity score demonstrated in Table 2.
The C-statistic, as estimated by ROC curve, was 0.549.
Model fitness was examined by the Hosmer and Leme-
show Goodness-of-Fit test, which indicates no signifi-
cant differences between actual and model-predicted
estimates (p = 0.311).
In brief, there seemed no major differences regarding
baseline demographic data such as age, gender distribu-
tion, blood pressures (both systolic and diastolic), body
mass index, waist circumference, glucose level (fasting
and post-prandial), HbA1c concentration, various lipid
profiles (cholesterol, triglyceride, HDL and LDL), as well
as life styles (smoking, exercise and alcohol consump-
tion behaviors) (all p for differences > 0.05). In addition,
we further demonstrated no differences of baseline
cardiometabolic risk scorings including ATP III, FRS
and eGFR (p = 0.296, 0.809 & 0.704, respectively).
Baseline to follow-up differences in various clinical
parameters and associated cardiometabolic risks
Results of baseline demographic and cardiometabolic
risk profiles of the t-test assessing differences after pro-
pensity matching at follow-up between intervention
and control groups are outlined in Table 3. For both
intervention and non-intervention groups, there were
no major differences regarding blood pressures (both
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systolic and diastolic), though significantly larger BMI
(p = 0.01) and waist circumference were observed at
the follow up visit in the non-intervention group (p =
0.012) with a significantly decrease in waist circumfer-
ence in the intervention group (p < 0.001). Further,
there were higher blood glucose level observed in the
non-intervention group at the follow up visit, together
with a higher HbA1c level (all p < 0.05). Furthermore,
higher total cholesterol, LDL and triglyceride levels
were observed at the follow up visit in the non-
intervention group (both p < 0.05). Compared to the
non-intervention group at follow up visit, we demon-
strated a significantly reduction in waist circumference,
post-prandial glucose, and total cholesterol level, result-
ing in significantly decrease of ATP III (−0.27 ± 0.08,
p = 0.001) and a borderline improvement in eGFR.
Difference-in-difference analysis of various clinical
parameters and associated cardiometabolic risks at
follow up
As presented in Table 4, the result of the DID analysis
for various variables before and after intervention obser-
vation period showed that there was substantial reduc-
tion in waist circumference, post-prandial glucose, total
cholesterol, higher HDL (all p < 0.05) and borderline re-
duction of BMI and LDL (p = 0.071 & 0.082, respect-
ively) when comparing the intervention to the non-
intervention group. As for life styles modification, we
also demonstrated in the intervention group that exer-
cise behavior significantly increased at the follow up
visit (p = 0.007 within group), and showed significant
differences when compared to the non-intervention
group (p = 0.014 between groups). These changes of
Table 1 Comparison of baseline data among study groups before and after propensity score matching
Initial cohort before PSA matching (N = 2,660) Cohort after PSA matching (N = 1004)
Variable Non-intervention
(n = 1,738)
Intervention (n = 922) Pa Non-intervention
(n = 502)
Intervention (n = 502) Pa
Demographical data
Age, year 40.93 (10.31) 44.85 (8.6) <0.001 44.52 (9.35) 44.81 (8.14) 0.609




117.32(15.04) 116.68 (14.55) 0.293 117.03 (13.75) 117.57 (14.67) 0.549
Diastolic blood pressure,
mmHg
73.43 (9.81) 73.45 (9.84) 0.946 73.34 (9.24) 73.86 (9.77) 0.387
Waist Circumference, cm 80.01 (10.18) 80.13 (9.59) 0.785 80.5 (9.3) 80.5 (9.8) 0.99
Body mass index, kg/m2 23.48 (3.32) 23.47 (3.15) 0.936 23.61 (2.86) 23.66 (3.21) 0.772
Serum sugar profiles
Fasting glucose, mg/dL 92.96 (13.83) 94.73 (15.76) 0.0033 94.22 (16.95) 94.22 (13.54) 1.000
Post-prandial glucose, mg/dL 101.51 (27.92) 103.73 (30.92) 0.139 104.16 (33.06) 103.75 (28.91) 0.846
HbA1c, % 5.43 (0.61) 5.53 (0.58) 0.048 5.41 (0.53) 5.51 (0.58) 0.063
Lipid Profiles
Total cholesterol, mg/dL 186.84 (32.90) 192.51 (33.42) <0.001 191.16 (31.98) 192.06 (33.85) 0.666
HDL, mg/dL 54.07 (13.97) 56.10 (14.68) 0.006 55.42 (14.75) 55.76 (14.58) 0.713
LDL, mg/dL 118.46 (30.45) 124.86 (32.10) <0.001 121.74 (29.55) 123.03 (31.11) 0.500
Triglyceride, mg/dL 110.05 (95.60) 115.96 (82.05) 0.151 112.83 (90.05) 113.45 (72.88) 0.917
Life style
Smoking, % 11.0% 17.0% <0.001 16.5% 17.3% 0.736
Alcohol Consumption, % 7.7% 18.3% <0.001 16.1% 15.7% 0.863
Exercise, % 23.9% 48.2% <0.001 43.6% 45.6% 0.526
Cardiometabolic Outcomes
ATP III, number of MetS 1.28 (1.23) 1.49 (1.30) <0.001 1.41 (1.27) 1.50 (1.27) 0.296
FRS, unit 4.57 (4.65) 4.97 (4.77) 0.132 4.68 (4.50) 4.76 (4.37) 0.809
eGFR, mL/min per 1.73 m2 86.05 (19.43) 84.30 (13.92) 0.028 83.51 (17.00) 83.88 (13.79) 0.704
adenotes either independent-sample t-test for continuous variable or chi-square test for categorical variable
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baseline variables between two groups over the ob-
served study period in turn further resulted in substan-
tially decrease of ATP III (−0.36 ± 0.06, p < 0.001) and a
borderline increase in eGFR (1.39 ± 0.8, p = 0.084) when
the intervention group was compared to the non-
intervention population.
Discussion
In the current study, we demonstrated that a strategic
health promotion intervention based on HIP improved
cardiovascular risks substantially in multiple dimen-
sions, which included waist reduction, decrease in post-
prandial glucose, cholesterol level as well as ATP III
score, which still holds true after DID analysis (HIP
versus non-HIP). The intervention programs also suc-
cessfully enhanced the level of physical activity, when
combined with the positive effects of previous bio-
chemical and anthropometric data, further resulted in
substantial reduction of metabolic scoring, and a bor-
derline improvement of renal function in terms of
eGFR. These results indicate that our health improve-
ment intervention provides evidence-based cardiometa-
bolic risks improvement in an Asian population during
the 3 years HIP in this study.
Owing to the rapid growth of several common risk
factors responsible for large invisible epidemic chronic
diseases burden including unhealthy diet, physical in-
activity and tobacco use, the World Health Organization
(WHO) had undertaken a series of programs and set a
goal to reduce the morbidity and mortality from such
diseases [13–15]. So far, it is well-known that both
health promotion and health education programs from
previous studies had successfully demonstrated the ef-
fectiveness on disease prevention or the cease of disease
Table 3 Difference between pre-test and post-test in each study group
Non-intervention group (n = 502) Intervention group (n = 502) Difference in posttest data
Variable Pretest Posttest Pa Pretest Posttest Pa Mean SE Pb
Physiologic parameters
Systolic blood pressure, mmHg 117.03 (13.75) 117.54 (14.85) 0.426 117.57 (14.67) 116.78 (13.94) 0.191 −0.76 0.91 0.403
Diastolic blood pressure, mmHg 73.34 (9.24) 73.48 (9.80) 0.719 73.86 (9.77) 73.88 (9.41) 1.000 0.40 0.61 0.513
Waist circumference, cm 80.5 (9.3) 80.98 (9.06) 0.012 80.5 (9.8) 79.51 (9.69) <0.001 −1.46 0.61 0.016
Body mass index, kg/m2 23.61 (2.86) 23.72 (2.93) 0.010 23.66 (3.21) 23.66 (3.23) 0.922 −0.06 0.20 0.740
Serum sugar profiles
Fasting glucose, mg/dL 94.22 (16.95) 95.95 (17.65) 0.001 94.22 (13.54) 95.12 (14.43) 0.079 −0.83 1.02 0.419
Post-prandial glucose, mg/dL 104.16 (33.06) 108.00 (33.89) 0.033 103.75 (28.91) 101.05 (25.45) 0.069 −6.77 2.06 0.001
HbA1c, % 5.41 (0.53) 5.69 (0.63) <0.001 5.51 (0.58) 5.72 (0.70) <0.001 0.04 0.06 0.524
Lipid Profiles
Total cholesterol, mg/dL 191.16 (31.98) 195.30 (34.93) <0.001 192.06 (33.85) 190.88 (32.78) 0.279 −4.42 2.15 0.040
HDL, mg/dL 55.42 (14.75) 56.10 (15.49) 0.110 55.76 (14.58) 55.21 (14.52) 0.039 −0.90 0.98 0.362
LDL, mg/dL 121.74 (29.55) 126.17 (32.39) <0.001 123.03 (31.11) 124.35 (30.86) 0.131 −1.81 2.07 0.380
Triglyceride, mg/dL 112.83 (112.05) 120.07 (90.42) 0.009 113.45 (72.88) 119.16 (73.29) 0.021 −0.91 5.24 0.862
Cardiometabolic Outcomes
ATP III, number of MetS 1.41 (1.27) 1.64 (1.29) <0.001 1.50 (1.27) 1.37 (1.26) 0.005 −0.27 0.08 0.001
FRS, unit 4.68 (4.50) 5.36 (4.71) 0.005 4.76 (4.37) 5.24 (4.58) 0.025 −0.08 0.34 0.807
eGFR, mL/min per 1.73 m2 83.51 (17.00) 84.62 (14.95) 0.087 83.88 (13.79) 86.39 (14.64) <0.001 1.72 0.94 0.068
Data not specified were presented as Mean (SD); adenotes paired-sample t-test; bdenotes independent-sample t-test
Table 2 The association between variables used to match with
propensity score
Variable Coefficient Standard error P
Age 0.003 0.008 0.649
Male gender 0.026 0.166 0.874
Systolic blood pressure, mmHg 0.002 0.005 0.743
Waist Circumference, cm −0.01 0.006 0.115
Body mass index, kg/m2 0.007 0.025 0.790
Fasting glucose, mg/dL −0.001 0.005 0.802
Total cholesterol, mg/dL −0.016 0.010 0.100
HDL, mg/dL 0.016 0.009 0.077
LDL, mg/dL 0.017 0.010 0.086
Triglyceride, mg/dL 0.002 0.001 0.186
Smoking 0.069 0.185 0.710
Alcohol −0.063 0.186 0.735
Exercise 0.049 0.132 0.710
Model fitness: C statistics = 0.549 P value of Hosmer and Lemeshow
Goodness-of-Fit test = 0.311
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progression, with special focus on indices related to
metabolic scorings which had been shown to be tightly
linked to community health [16, 17]. Tovar et al. had
recently demonstrated that active control on diet con-
tents may show beneficial effects on several cardiometa-
bolic parameters including sugar level, several lipid
profiles as well as blood pressure, which indicated the
potentiality of dietary control based on the view points
of primary preventive medicine [18]. Jahangiry et al. also
ever published data regarding effects of lifestyle modifi-
cation on metabolic syndrome in a dedicated designed
randomized control trial, though in which study the case
numbers are relatively small. In our current work, we
similarly demonstrated that dietary modifications by
active intervention showed positive effects on several
lipid profiles, including drastic decline of total choles-
terol, significant increase of HDL and borderline drop in
LDL level, as well as improvement in post-prandial
sugar control.
On the other hand, the significance of physical activity
during lifestyle intervention had also been addressed
and reported by Kujala et al., who observed a substan-
tial decrease in both body weight and waist circumfer-
ence for those at high risk for type 2 diabetes subjects
but capable of carrying out higher physical activity level
in the past 1 year [19]. The significant increase of exer-
cise behavior and the substantial decrease of waist
circumference and borderline decline of BMI at follow
up visit in the HIP compared to the non-HIP group in
our current study. In a previous report by Grundy et al.,
they showed that physical activity and weight reduction
can act as first line therapy for metabolic syndrome [20,
21]. In our current work, we showed similar results in
that HIP may effectively reduce metabolic scoring via
increased physical activity and significantly reduced
waist circumference, which was believed to be the key
pathological component of metabolic syndrome. Our
current data further extended beyond their findings in
that we showed that these effects may be attributable to
decreased total cholesterol, lowered post-prandial glu-
cose as well as elevated HDL level.
Persistent physical training had been shown to be
beneficial for prevention and disease management of
diabetes and cardiovascular diseases [22–25]. Healthy
diet controls, on the other hand, had also been shown to
result in desirable health management results [26]. Of
note, we showed that the clinical variables most subject-
ive to the intervention therapy were waist circumference,
body mass, post-prandial glucose level, renal function as
well as several lipid profiles. There effects, when taken
together, in part may help to explain the substantial
improvement of metabolic scores at follow-up visit.
The strength of our work is the less biased nature of
subjects enrolled for comparison between the HIP and





Difference in difference (Intervention minus non-intervention)
Variable Mean SD Mean SD Mean SE Pa
Physiologic parameters
Systolic blood pressure, mmHg 0.53 14.92 −0.81 13.77 −1.34 0.91 0.141
Diastolic blood pressure, mmHg 0.16 10.08 0.00 9.73 −0.16 0.63 0.795
Waist Circumference, cm 0.72 5.95 −0.96 6.04 −1.69 0.4 <0.001
Body mass index, kg/m2 0.12 1.01 0.00 0.97 −0.11 0.06 0.071
Serum sugar profiles
Fasting glucose, mg/dL 1.72 11.06 0.92 11.70 −0.79 0.72 0.271
Post-prandial glucose, mg/dL 3.74 32.28 −2.30 27.01 −6.04 2.10 0.004
HbA1c, % 0.26 0.33 0.22 0.62 −0.05 0.05 0.315
Lipid Profiles
Total cholesterol, mg/dL 4.13 23.92 −1.08 22.16 −5.21 1.47 <0.001
HDL, mg/dL −0.76 7.89 0.63 8.51 1.38 0.54 0.010
LDL, mg/dL 3.85 22.95 1.40 19.96 −2.45 1.41 0.082
Triglyceride, mg/dL 7.17 60.98 5.43 52.17 −1.74 3.61 0.630
Cardiometabolic Outcomes
ATP III, number of MetS 0.23 1.02 −0.12 0.96 −0.36 0.06 <0.001
FRS, unit 0.55 3.49 0.41 3.24 −0.15 0.27 0.582
eGFR, mL/min per 1.73 m2 1.10 14.24 2.48 10.71 1.39 0.80 0.084
SD = standard deviation; SE = standard error of the mean difference; adenotes independent-sample t-test
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non-HIP groups by utilizing propensity matching simu-
lating randomized design from a relatively large Asian
cohort since we fully acknowledged that potential selec-
tion bias in our work could not be avoided. The conduc-
tion of propensity matching may theoretically reduce
the risks of baseline demographic distribution and the
biochemical differences as much as possible. Further-
more, we conducted a propensity matching (PS) and
difference-in-difference analysis (DID) which allows
analysis of these effects less biased and to minimize the
potential differences for those subjects with and with-
out intervention during some period of follow-up. Even
though, we still consistently showed the advantage of
participating intervention programs in cardiometabolic
risk reduction. To our best knowledge, there is a paucity
of published studies that address relevant issues with rela-
tive large number of subjects enrolled from health evalu-
ation center so far with meaningful results reported.
While previous data on observational community-based
reports seldom compare the potential effects of health
promotion programs based on more strict study design
with control group, our current data may provide invalu-
able information about the feasibility and usefulness of
these programs implemented on a daily basis in tertiary
care system [18, 27–30].
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